Bain Capital Life Sciences Investors, LLC Nurix Therapeutics, Inc. Transaction History

Bain Capital Life Sciences Investors, LLC

  • $557 Million
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024
SELL
$7.77 - $15.66 $5.37 Million - $10.8 Million
-690,486 Reduced 37.88%
1,132,397 $16.6 Million
Q2 2022

Aug 15, 2022
BUY
$7.88 - $14.82 $4.24 Million - $7.98 Million
538,570 Added 41.93%
1,822,883 $23.1 Million
Q4 2021

Feb 14, 2022
SELL
$26.43 - $34.5 $26 - $34
-1 Reduced -0.0%
1,284,313 $37.2 Million
Q3 2020

Nov 16, 2020
BUY
$16.05 - $34.91 $20.6 Million - $44.8 Million
1,284,314 New
1,284,314 $44.8 Million

Others Institutions Holding NRIX

# of Institutions
181
Shares Held
68.1M
Call Options Held
78K
Put Options Held
53.8K
View Full List

About Nurix Therapeutics, Inc.

NRIX Quotes by TradingView
  • Ticker NRIX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 47,147,800
  • Market Cap $1.03B
  • Description
  • Nurix Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of small molecule therapies for the treatment of cancer and immune disorders. The company develops NX-2127, an orally available Bruton's tyrosine kinase (BTK) degrader for the treatment of relapsed or refractory B-cell malignancies...
More about NRIX
Track This Portfolio

Track Bain Capital Life Sciences Investors, LLC Portfolio

Follow Bain Capital Life Sciences Investors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bain Capital Life Sciences Investors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Bain Capital Life Sciences Investors, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email